Anavex Life Sciences Corp (AVXL)
9.02
+0.54
(+6.43%)
USD |
NASDAQ |
Nov 21, 16:00
9.035
+0.02
(+0.17%)
After-Hours: 20:00
Anavex Life Sciences Total Liabilities (Quarterly): 11.75M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.75M |
| March 31, 2024 | 9.558M |
| December 31, 2023 | 12.50M |
| September 30, 2023 | 12.53M |
| June 30, 2023 | 11.06M |
| March 31, 2023 | 14.02M |
| December 31, 2022 | 13.25M |
| September 30, 2022 | 10.21M |
| June 30, 2022 | 9.484M |
| March 31, 2022 | 8.071M |
| December 31, 2021 | 10.53M |
| September 30, 2021 | 10.80M |
| June 30, 2021 | 9.274M |
| March 31, 2021 | 7.764M |
| December 31, 2020 | 8.034M |
| September 30, 2020 | 7.306M |
| June 30, 2020 | 6.949M |
| March 31, 2020 | 6.229M |
| December 31, 2019 | 5.464M |
| September 30, 2019 | 5.040M |
| June 30, 2019 | 4.337M |
| March 31, 2019 | 6.371M |
| December 31, 2018 | 4.876M |
| September 30, 2018 | 3.885M |
| June 30, 2018 | 3.209M |
| Date | Value |
|---|---|
| March 31, 2018 | 3.417M |
| December 31, 2017 | 2.798M |
| September 30, 2017 | 3.584M |
| June 30, 2017 | 1.455M |
| March 31, 2017 | 2.120M |
| December 31, 2016 | 2.195M |
| September 30, 2016 | 3.190M |
| June 30, 2016 | 2.173M |
| March 31, 2016 | 2.432M |
| December 31, 2015 | 2.533M |
| September 30, 2015 | 2.661M |
| June 30, 2015 | 1.410M |
| March 31, 2015 | 1.662M |
| December 31, 2014 | 6.577M |
| September 30, 2014 | 7.161M |
| June 30, 2014 | 1.905M |
| March 31, 2014 | 1.884M |
| December 31, 2013 | 1.821M |
| September 30, 2013 | 2.857M |
| June 30, 2013 | 3.557M |
| March 31, 2013 | 3.435M |
| December 31, 2012 | 3.409M |
| September 30, 2012 | 2.888M |
| June 30, 2012 | 2.220M |
| March 31, 2012 | 3.120M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.464M
Minimum
Dec 2019
14.02M
Maximum
Mar 2023
9.725M
Average
9.558M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
| Oragenics Inc | 2.126M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.54M |
| Shareholders Equity (Quarterly) | 129.78M |